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Abstract 
Background: Nanoparticles’ unique features have been highly explored in cellular therapies. However, nanoparti-
cles can be cytotoxic. The cytotoxicity can be overcome by coating the nanoparticles with an appropriated surface 
modification. Nanoparticle coating influences biocompatibility between nanoparticles and cells and may affect some 
cell properties. Here, we evaluated the biocompatibility of gold and maghemite nanoparticles functionalized with 
2,3-dimercaptosuccinic acid (DMSA), Au-DMSA and γ-Fe2O3-DMSA respectively, with human mesenchymal stem cells. 
Also, we tested these nanoparticles as tracers for mesenchymal stem cells in vivo tracking by computed tomography 
and as agents for mesenchymal stem cells magnetic targeting.
Results: Significant cell death was not observed in MTT, Trypan Blue and light microscopy analyses. However, ultra-
structural alterations as swollen and degenerated mitochondria, high amounts of myelin figures and structures similar 
to apoptotic bodies were detected in some mesenchymal stem cells. Au-DMSA and γ-Fe2O3-DMSA labeling did not 
affect mesenchymal stem cells adipogenesis and osteogenesis differentiation, proliferation rates or lymphocyte 
suppression capability. The uptake measurements indicated that both inorganic nanoparticles were well uptaken by 
mesenchymal stem cells. However, Au-DMSA could not be detected in microtomograph after being incorporated by 
mesenchymal stem cells. γ-Fe2O3-DMSA labeled cells were magnetically responsive in vitro and after infused in vivo in 
an experimental model of lung silicosis.
Conclusion: In terms of biocompatibility, the use of γ-Fe2O3-DMSA and Au-DMSA as tracers for mesenchymal stem 
cells was assured. However, Au-DMSA shown to be not suitable for visualization and tracking of these cells in vivo by 
standard computed microtomography. Otherwise, γ-Fe2O3-DMSA shows to be a promising agent for mesenchymal 
stem cells magnetic targeting.
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microtomography, Magnetic targeting, DMSA-nanoparticles
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Background
Due to the progression of nanotechnology, there are 
new materials at the nanometer scale that have been 
introduced to the Medicine [1]. One promising medical 
application of nanomaterials is the use of inorganic nano-
particles within mesenchymal stem cells (MSCs)-based 
therapies: nanomaterials have facilitated not only the 
investigation of stem cells’ biology but also the develop-
ment of new approaches for their expansion, differentia-
tion and transplantation. Some of these nanomaterials 
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possess chemical, optical or magnetic properties which 
can be used for visualization and tracking of MSCs [2–6].
Among the nanoparticles, iron oxide nanoparticles 
(IONPs) have great prominence because of their super-
paramagnetism, a property highly valued for biomedi-
cal applications [7]. Due to the strong signal that IONPs 
generate in magnetic resonance imaging, it is possible 
to visualize cells in microscopic levels and get specific 
information about their distribution in  vivo [3, 7–9]. In 
addition, IONPs’ magnetic properties can be explored for 
magnetically assisted cell delivery and retention in target 
organs [10–12], which is one of major current challenges 
in cell therapy. Lastly, IONPs superparamagnetism has 
also been applied in hyperthermia therapies in tumors, 
taking advantage of MSCs tropism to tumor cells [9].
Recently, another class of inorganic nanoparticles, 
gold nanoparticles (Au-NPs), has been explored in cell 
based therapies. It is known that nanoscale gold strongly 
absorbs and scatters visible light—a phenomenon that is 
based on the occurrence of surface plasmons [13]. There-
fore, Au-NPs have been used for stem cells marking, 
which can be detected in vivo by fluorescence or photo-
thermal imaging [6, 14–16]. Moreover, as Au-NPs scatter 
X-rays efficiently, labeled MSCs can also be detected by 
computed tomography, a technique that provides greater 
spatial resolution compared to magnetic resonance imag-
ing [5, 6, 17, 18].
Despite their potential in clinical practice, the impacts 
of IONPs and Au-NPs on MSCs are not entirely clear. 
First, both materials can be toxic to cells. It is known that 
transition metals such as iron, when retained in excess in 
cell cytoplasm in a non-complexed form, act as catalysts 
for oxidation reactions of biomolecules, then increasing 
the rate of free radicals generation [19, 20]. On the other 
hand, even though macroscopic gold appears chemi-
cally inert, at the nanometric scale it may induce oxida-
tive stress and it can bind permanently to nuclear and 
mitochondrial DNA [21–26]. There are also some studies 
showing unexpected physiological alterations in nano-
particle labeled MSCs, such as changes in differentiation 
ability [25–29] and in growth rates [26, 30]. These obser-
vations reinforce the importance of conducting previ-
ous biocompatibility tests of these nanoparticles before 
in vivo procedures [31, 32].
Coating nanoparticles with a proper surface modifica-
tion is a strategy largely used to decrease potential toxic 
effect on cells. Biomedical applications of nanoparticles 
require surface modifications of nanoparticles in order 
to make them non-toxic, biocompatible, non-agregable 
and stable [33]. Surface functionalization of inorganic 
particles with 2, 3-dimercaptosuccinic acid (DMSA) is 
considered to be a promising strategy to increase bio-
compatibility [34, 35].
Here, we aimed to investigate the biocompatibility and 
potential use of two inorganic nanoparticles coated with 
DMSA, iron oxide nanoparticles coated with DMSA 
(γ-Fe2O3-DMSA) and gold nanoparticles coated with 
DMSA (Au-DMSA) used to label human MSC. Further, 
these nanoparticles were tested on two practical appli-
cations: Au-DMSA nanoparticles were tested as tracers 
for MSC in vivo tracking by computed tomography; and 
γ-Fe2O3-DMSA as agents for magnetic targeting of MSC.
Methods
Nanoparticles synthesis and characterization
Maghemite nanoparticles were prepared via oxidation 
of precursor magnetite nanoparticles, as described in 
the literature. γ-Fe2O3 nanoparticles were synthesized by 
mixing ferric and ferrous chloride aqueous solutions (2:1 
molar ratio) with concentrated ammonia aqueous solu-
tion followed by vigorous stirring. The black magnetite 
precipitate was washed several times with water and col-
lected by a magnet. The oxidation of magnetite to magh-
emite was carried out by refluxing the nanoparticles in 
0.5  mol/L hydrochloric acid (HCl) solution under oxy-
gen flux at 96  °C, yielding a brownish colloidal suspen-
sion. The brown precipitate was extensively washed using 
the 1 mol/L HCl solution and decanted by a magnet. The 
sample was redispersed in water and dialyzed against 
demineralized water to produce an aqueous acidic mag-
netic dispersion. The meso-2,3-dimercaptosuccinic acid 
(DMSA) coated maghemite nanoparticles (γ-Fe2O3-
DMSA) was prepared according the early described pro-
tocol [36]. Five millilitre of DMSA (Acros Chemicals) 
stock solution (0.3 mol/L) were added to the 25 mL of the 
dispersion of maghemite nanoparticles in a molar ratio 
DMSA/Fe of 11 %. The dispersion was shacked for 12 h 
at room-temperature. Then, the dispersion was dialyzed 
for 12 h against demineralized water to eliminate the free 
DMSA out from the bulk solution. The pH was adjusted 
to the range of 7.0–7.2 and the suspension containing 
the maghemite nanoparticles functionalized with DMSA 
was purified against large aggregates by centrifugation at 
5000 rpm for 10 min.
The total iron and gold content in the suspensions were 
determined by Atomic absorption spectrophotometry in 
a commercial Perkin-Elmer 5000 system (Perkin-Elmer, 
Norwalk, USA). The Fe2+/Fe3+ ratio was determined by 
the 1–10 phenanthroline colorimetric method. X-ray 
powder diffraction (XRD) data were collected by a XRD-
6000 diffractometer (Shimadzu, Kyoto, Japan). The aver-
age diameter of the nanocrystalline domain (d) was 
estimated using the Scherrer’s equation [37]. Electronic 
micrographs of maghemite nanoparticles were obtained 
with a JEOL JEM 2100 Transmission Electron Micros-
copy (TEM). Hydrodynamic diameter and zeta potential 
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measurements were performed using the Malvern Zeta-
sizer Nano-ZS (Malvern Instruments Ltd., Worcester-
shire, UK).
The synthesis of the DMSA coated gold nanoparticles 
(Au-DMSA) was carried out by following the method 
purposed by Gao et al. [38]. Shortly, 5 mL of an aqueous 
DMSA solution 1.8 × 10−3 mol/L was added to 25 mL of 
an aqueous HAuCl4 solution 6 × 10−4 mol/L at the boil-
ing point, and the system was maintained under stirring 
by 15  min. After cooling to room temperature the col-
loidal suspension was against demineralized water and 
stored in the dark.
The total gold content in the metallic suspensions were 
determined by Atomic absorption spectrophotometry in 
a commercial Perkin-Elmer 5000 system (Perkin-Elmer, 
Norwalk, USA). Au-DMSA nanoparticle morphology 
was examined using a JEOL JEM 2100 TEM. Au-DMSA 
particle size was measured by dynamic light scattering 
(DLS) and zeta potential measurements were performed 
using Malvern Zetasizer Nano-ZS.
Cells
Dental pulp tissues were obtained from the permanent 
teeth of patients (17–43  years of age) under approval 
of the Ethical Committee of Health Sciences Faculty 
of the University of Brasília (Brazil) (Project number 
023/08), as previously described [39]. All pulp tissues 
were washed with a-MEM, digested with 3  mg/mL col-
lagenase type I (Gibco) in supplemented medium for 
60 min at 37  °C. After enzymatic digestion, cell suspen-
sion was washed three times by centrifugation (10  min 
at 750g) in culture medium and placed into 6-well plates. 
The human MSC obtained were cultured in Low-Glu-
cose Dulbecco’s Modified Eagle Medium (DMEM-LG) 
(GIBCO®, Invitrogen,Carlsbad, CA) supplemented with 
1  % l-glutamine (GIBCO®, Invitrogen, Carlsbad, CA), 
1  % antibiotic–antimycotic (10,000  UI/mL penicillin, 
10,000  mg/mL streptomycin and 25  µg/mL Ampho-
tericin B) (GIBCO®, Invitrogen, Carlsbad, CA) and 10 % 
fetal bovine serum. MSC were grown under standard cell 
culture conditions (37 °C, 5 % CO2) and have been main-
tained to their confluence below 80 %. Only passage 3–4 
cells were used in this study.
Assessment of cell viability and morphology
The MSC were exposed to γ-Fe2O3-DMSA (15, 30, 60 
and 80 µg iron/mL) and to Au-DMSA (52, 90 and 130 µg 
gold/mL) in growth medium for 02, 06 or 24 h. After each 
exposition time, labeled MSC viability was evaluated by 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromide) assay [40], by Trypan blue exclusion assay 
[41] and by cell morphology analysis. For MTT assay, 
MSC were exposed to γ-Fe2O3-DMSA and Au-DMSA 
during 02, 06 or 24  h. In Trypan blue exclusion assay, 
MSC were incubated with nanoparticles only during 
24  h. For evaluation of cell morphology, labeled MSC 
were incubated for 24  h with DMEM-LG with serum 
(negative control group), with DMEM-LG without serum 
(positive control group), with γ-Fe2O3-DMSA nanopar-
ticles (80  µg iron/mL) or with Au-DMSA nanoparticles 
(90  µg gold/mL). After incubation time, the cells were 
stained with Instant Prov Kit (Newprov) according to the 
manufacturer’s recommendations and observed analyzed 
using an inverted microscope (Axiovert 100, Zeiss).
Nanoparticle uptake
After 24 h of incubation, the cells were washed, ressus-
pended in PBS and counted using an automatic counter 
(Scepter ™, Millipore). Prussian blue staining was used 
to quantify the amount of uptaken γ-Fe2O3-DMSA, as 
described by Boutry et al. [42], with some modifications: 
100 µl of 5 N HCl were added to the samples, incubating 
them at 80 ℃ for 4  h to lyse cells. After that, the sam-
ples were transferred to a 96-well polystyrene plate and 
100 mL of 5 % potassium ferrocyanide were added. The 
absorbance of samples at 630 nm was measured and data 
were compared with a standard curve whose function 
relates the Prussian blue OD630  nm with iron concentra-
tion in the sample. The results are expressed as iron per 
cell.
Inductively coupled plasma optical emission spectrom-
etry (ICP-OES) technique (Spectro Arcos, Ametek) was 
used to measure the amount of intracellular gold after 
exposure to the Au-DMSA (90 µg gold/mL) for 24 h.
Transmission electron microscopy analysis
After incubation of MSC with Au-DMSA (90  µg gold/
mL) and γ-Fe2O3-DMSA (80  µg iron/mL), as described 
previously, they were fixed in modified Karnovsky’s fixa-
tive (2 % paraformaldehyde, 2.5 % glutaraldehyde in 0.1 M 
sodium cacodylate buffer, pH 7.2) for 2  h at room tem-
perature. Samples were postfixed in solution containing 
1 % osmium tetroxide, 0.8 % potassium ferricyanide, and 
5 mM calcium chloride and contrasted in bloc with 0,5 % 
uranyl acetate. Samples were then dehydrated in acetone 
and embedded in Spurr. Semi-thin sections (3 μm) were 
stained with toluidine blue and examined under a light 
microscope to localize cells with visible nucleus. Ultra-
thin sections (70  nm) were examined using a Tecnai 
Spirit G2 TEM (FEI, USA).
MSC differentiation
To verify if both nanoparticles interfere with the MSC 
ability to differentiate, the cells were cultured in medium 
enriched with inducing agents, after their exposure 
to γ-Fe2O3-DMSA (80  µg/mL) and Au-DMSA (90  µg/
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mL) for 24  h. For the experiments of differentiation 
into osteoblasts, the cell inducers used were dexameth-
asone (5 ×  10−6  M); ascorbic acid (2.8 ×  10−4  M); and 
β-glycerol phosphate (10−2 M). Subsequently, cytochemi-
cal analyses with specific labeling with dyes were per-
formed. The MSCs differentiated into osteoblasts were 
fixed in 50 % ethanol for 15 min at 4 °C and stained with 
a solution of Alizarin Red S 1 %. Quantitative analysis of 
osteogenic differentiation was performed by quantifica-
tion of Alizarin Red S adhered to calcified tissues, fol-
lowing the protocol adopted by Gregory et  al. [43], and 
measurement of alkaline phosphatase (ALP) activity, by 
the colorimetric method of para- nitrophenol [44], using 
the kit SIGMAFAST p-Nitrophenyl phosphate tablets 
(Sigma) according to the manufacturer’s recommenda-
tions. The corresponding values of enzyme activity in 
milliunits (mIU) per milliliter were divided by the total 
protein content (in µg) of the monolayer, estimated by 
the Lowry method [45].
To induce differentiation into adipocytes, the inducers 
used were dexamethasone (5  ×  10−6  M); 0.3-isobutyl-
methylxanthine (4.5 ×  10−4  M); insulin (5  μg/mL); and 
indomethacin (3 × 10−4 M). After 24 days, the cells dif-
ferentiated into adipocytes were fixed with formaldehyde 
solution for 15  min, and stained with a solution of “Oil 
Red O” at 0.3 % for 20 min for cytochemical analysis. An 
indirect measurement of adipogenesis was performed 
by quantification of Oil Red O in MSC monolayers add-
ing 100 % isopropanol to extract the dye and measure its 
absorbance at 510 nm.
MSC growth curve
MSC were cultivated in 75 cm2 culture flasks until they 
reached 80  % confluence. The growth curve was per-
formed by incubating the cells with DMEM-LG (control), 
with γ-Fe2O3-DMSA (80  µg/mL), and with Au-DMSA 
(90  µg/mL). The cells were washed, disassociated from 
the flasks and seeded in 12-well cell culture plates at a 
starting concentration of 10,000 cells per well. Then, they 
were collected after six different times of incubation (2, 
4, 6, 8, and 10  days), stained with Trypan blue dye and 
counted. The results are expressed as percentage of live 
cells.
Suppression of lymphocyte proliferation by MSC
Human mononuclear cells were isolated by Ficoll-Paque 
gradient. Briefly, blood were collected, stored in tubes 
containing anticoagulants, diluted in phosphate buffered 
saline (PBS) and transferred to a centrifuge tube, over 
a Ficoll-Paque layer (ρ  =  1.077  g/mL). The tubes were 
centrifuged at 2000  rpm for 25  min, and the mononu-
clear cell layer obtained was then transferred to a new 
centrifuge tube. The mononuclear cells were counted 
using a Neubauer chamber (Gibco), resuspended at a 
final concentration of 107 cells/mL and labeled with Car-
boxyfluorescein succinimidyl ester (CFSE), according to 
manufacturer recommendations (CellTrace™ CFSE dye, 
Life Technologies). Lymphocytes then received allogeneic 
stimulus in the presence or absence of MSC for 5 days.
Murine model of silicosis
All experimental protocols with animals in this study 
were approved by the animal experimentation eth-
ics committee of University of Brasilia (certificate # 
99769/2012). C57BL/6 mice, 8  weeks old, were ran-
domly divided into: control group, instilled intratra-
cheally with 50  μL of sterile saline; and silicosis group, 
instilled intratracheally with a silica particle suspension 
(20  mg/50  μL of saline). In this model, the pathophysi-
ological characteristics of silicosis are observed 15  days 
after installation of crystalline silica [46].
Computed tomography analysis
The application of Micro-CT to tracking Au-DMSA 
labeled MSCs in  vivo was tested using a 1076 Skyscan 
microtomography device (Skyscan, Aartselaar, Belgium). 
The mice were analyzed daily in the equipment until the 
7th day after the inoculation of Au-DMSA labeled MSCs 
or saline. Images were acquired using voltage 50 kV, cur-
rent 180 mA, 0.5 mm aluminum filter and isotropic voxel 
size of 18  μm. For the two-dimensional image recon-
struction, we used NRecon software (V 1.6.9, 64 bit ver-
sion with GPU acceleration, Skyscan, Kontich, Belgium). 
For three-dimensional reconstructions, we used CTVox 
software (V 1.5.0, 64 bit version, Skyscan, Kontich, Bel-
gium) and CTVol software (2.2  V, 64 bit version, Skys-
can, Kontich, Belgium). Analyses of reconstructions were 
performed using the software CTAnalyzer (V 1.5.0, 64 
bit version, Skyscan, Kontich, Belgium). The most appro-
priate parameters of smoothing, ring artifacts correction 
and beam-hardening correction were used. All acquisi-
tion and reconstruction parameters were the same for all 
mice.
Magnetic targeting of γ‑Fe2O3‑DMSA labeled MSC
γ-Fe2O3-DMSA nanoparticles were tested as potential 
agents for MSC magnetic targeting to injured lungs. The 
cells were incubated with 80  µg/mL of γ-Fe2O3-DMSA 
for 24 h and inoculated into silicotic mice. Neodymium 
circular magnets (20 mm in diameter and 2 mm height) 
were held in the thoracic region of some animals for up 
to 24 h. 48 h after inoculation of MSC, the animals were 
euthanized and their lungs were collected for iron quanti-
fication following the protocol described by Boutry et al. 
[42], and histological analysis. Slides containing lung sec-
tions were also stained with Prussian blue.
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Statistical analysis
The normality of the data was analyzed by the Kolmogo-
rov–Smirnov test. Then, the parametric test ANOVA, 
followed by post hoc Tukey’s test was performed for sta-
tistical comparison of data of the following experiments: 




According to Atomic absorption spectrophotometry 
data, the γ-Fe2O3-DMSA solution used in this study has 
4.09  mg of iron per mL. In addition, γ-Fe2O3-DMSA 
nanoparticles present zeta potential of −43 ±  0.66  mV, 
irregular shape from square to sphere in TEM micro-
graphs (Fig. 1a) and nanocrystalline diameter in a range 
of 5–18  nm, as determined by Scherrer’s equation with 
XRD data (data not showed).
On the other hand, Au-DMSA solution presented low 
gold concentration—0.07 mg/mL—hindering XRD anal-
ysis; thus, Au-DMSA particle size was determined by 
Dynamic Light Scattering: 26.4 ±  0.96  nm. Similarly to 
γ-Fe2O3-DMSA nanoparticles, Au-DMSA also has nega-
tive zeta potential—40.8  ±  3.70  mV—and has spherical 
morphology in TEM micrographs (Fig. 1b).
Cytotoxicity assays
According to the MTT assay, MSC exposed to γ-Fe2O3-
DMSA nanoparticles (15, 30, 60 and 80  µg iron/mL) 
remained viable, with no difference between experi-
mental groups and their respective control groups at 
any incubation time (Fig.  2a). Differently, there was a 
20–25  % reduction in the cell viability when they were 
exposed to Au-DMSA for 24 h, compared to the control 
cells (Fig. 2b). However, no difference was observed after 
48 and 72 h of exposure (Fig. 2c).
The data of Trypan Blue dye test also demonstrate that 
γ-Fe2O3-DMSA (60 and 80  µg/mL) is not cytotoxic to 
MSCs, approximately 98  % of cells remained alive after 
24 h of incubation. Interestingly, this test also indicated 
that at least 97.6 % of the cells exposed to Au-DMSA (52 
and 90 µg/mL) also survived (Fig. 2d).
The morphological analysis of MSC under light micro-
scope (Fig. 3) showed, as expected,that the negative con-
trol group MSC (Fig.  3a) presented a spindle form and 
a large nucleus. Otherwise, cells in the positive control 
group (Fig.  3b) showed pyknotic nuclei, a sign of apop-
tosis, after being cultured in serum-depleted media for 
24 h. MSCs exposed to 80 µg/mL Fe2O3-DMSA (Fig. 3c) 
and to 90 µg/mL Au-DMSA (Fig. 3d) for 24 h were simi-
lar to the negative control MSCs, without cell shrinkage 
or pyknosis.
Nanoparticle uptake
The amount of γ-Fe2O3-DMSA nanoparticles (80 μg/mL) 
uptaken by MSCs after 24 h, measured by Prussian Blue 
colorimetric quantification indicated that each cell con-
tain approximately 17 pg of iron, while control cells only 
5  pg. ICP-OES measurement indicated that each MSC 
retained approximately 4 pg of gold after exposure to Au-
DMSA (90 μg/mL) for 24 h.
In the Fig. 3, TEM analysis confirms the uptake of nan-
oparticles by MSC (Fig. 4a–c). Fe2O3-DMSA (Fig. 4b) and 
Au-DMSA (Fig. 4c) are free in the cell cytoplasm, inside 
vesicles, or in different cellular compartments, particu-
larly into mitochondria.
Compared to unlabeled MSCs, Au-DMSA labeled cells 
presented a similar ultrastructure, however, few differ-
ences were observed: concentric electron dense myelin 
figures (Fig.  4d) and electron-lucent vesicles (Fig.  4e). 
Likewise, γ-Fe2O3-DMSA labeled cells presented swollen 
and degenerated mitochondria, full of iron in their ridges 
(Fig.  4f ) and myelin figures (Fig.  4g). Lastly, γ-Fe2O3-
DMSA labeled MSC had higher amounts of nanopar-
ticles into cytoplasmic vesicles, different to Au-DMSA 
labeled cells (Fig. 4g).
Fig. 1 Transmission electron microscopy analysis of γ-Fe2O3-DMSA and Au-DMSA. a TEM micrographs of Fe-DMSA nanoparticles, bars 50 nm.  
b TEM micrographs of Au-DMSA nanoparticles, bars 50 nm
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Impact of DMSA‑nanoparticles in MSC physiology
MSC differentiation
After 24  days of treatment with osteogenic medium, 
we observed the formation of calcified nodules in MSC 
monolayers of all experimental groups (Fig. 5a–c). How-
ever, it was possible to see that there were fewer calcified 
nodes in the cells with Au-DMSA, while there were more 
in MSC monolayers with γ-Fe2O3-DMSA. This difference 
was confirmed after the measurement of the amount of 
Alizarin Red (ARS) absorbed by mineralized nodules 
(Fig. 5d).
In order to corroborate this data, we performed the 
measurement of alkaline phosphatase (ALP) activity in 
labeled and unlabeled MSC, using p-nitrophenylphos-
phate as substrate. Contrary to what was seen in ARS 
measurement test, there was no statistically significant 
difference between control cells and both experimental 
groups (Fig. 5e).
Intracellular lipid vacuoles were observed in MSCs 
after 24  days of incubation with adipogenic medium, 
showing that differentiation occurred in control and 
experimental groups (Fig.  6a–c). No difference in the 
amount of Oil Red O dye from differentiated MSC 
monolayers was observed in all experimental groups 
(Fig. 6d).
MSC proliferation and lymphocyte suppression
The results of total cell number by trypan blue staining, in 
order to assess the proliferative potential of labeled MSC 
are expressed in Fig. 7a, b. According to the individual-
ized data analysis, there were no significant differences 
among the number of cells labeled with γ-Fe2O3-DMSA 
and control cells in any times (Fig. 7a). Au-DMSA labeled 
MSC showed cell number increase after 2 days of incuba-
tion (Fig. 7b).
To verify whether nanoparticle uptake influence the 
characteristic capability of MSC to cause unspecific 
lymphocyte suppression in vitro a lymphocyte prolifera-
tion test was performed. Lymphocytes were labeled with 
CFSE and their proliferation rates were analyzed by flow 
cytometry (Fig. 7c). Their proliferation leads to an intra-
cellular reduction of the fluorescent tracer, decreasing 
its intensity, as shown in the Fig.  7c (red line). Because 
of the activation (and subsequent division) of these 
mononuclear cells in the control group, there are several 
populations with different amounts of marker, therefore, 
Fig. 2 Cell viability assessment by MTT and Trypan-blue staining. a MTT assay of γ-Fe2O3-DMSA labeled MSC. The data express average percent-
age and standard deviation of MSC that have remained viable after exposure to γ-Fe2O3-DMSA in four different concentrations at three different 
exposure times. b MTT assay of Au-DMSA labeled MSC. The average percentage and standard deviation of viable MSC are represented after 24 h 
of exposure to three different concentrations of Au-DMSA. (*) Significant reduction between the cells of the three experimental groups compared 
to the control group (p < 0.01). c MTT assay of Au-DMSA labeled MSC 4, 24, 48 and 72 h after incubation with the nanoparticles (90 µg/mL) during 
24 h. There were significant differences between control cells and labeled cells only 4 and 24 h after exposure (p < 0.05). d Cell viability test by 
trypan-blue staining. The data express the mean percentage and standard deviation of MSC that remained alive after 24 h of exposure to 52 and 
90 µg/mL of Au-DMSA and 60 and 80 µg/mL of γ-Fe2O3-DMSA
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the red line span multiple fluorescence intensity values. 
Based on this, the representative curve of the negative 
control group that does not contain activated lympho-
cytes (black line), remained narrow. Finally, it was found 
in this experiment that lymphocytes, either after the co-
cultivation with unmarked MSC (blue line), either with 
γ-Fe2O3-DMSA labeled MSC (green line) or Au-DMSA 
marked cells (yellow line), not proliferated.
Thus, all these results suggest that exposure to γ-Fe2O3-
DMSA and Au-DMSA nanoparticles, at the tested con-
centrations, does not cause toxic effects to MSC and do 
not change their physiology. Therefore, both inorganic 
nanoparticles are biocompatible with MSCs.
Computed tomography analysis
Firstly, a test was performed in which tubes containing 
precipitates of unlabeled MSC or Au-DMSA labeled cells 
(90 μg/mL, 24 h) were scanned in a micro-CT equipment 
to assess whether nanoparticles generate adequate con-
trast (Fig. 8a–c). The parameters of acquisition and image 
reconstruction were adjusted similarly to those used in 
analysis with mice. A tube containing water served as 
control, and the signal generated by the liquid was then 
considered as 0 (zero) Hounsfield (HU). The values in 
Hounsfield scale for each sample were: 284.70 HU in con-
trol MSC and 352.79 HU in Au-DMSA labeled MSC.
Although the Au-DMSA has generated a visible con-
trast in images of cell precipitates, labeled MSCs were 
not detected by the device after its inoculation in mice in 
any analyzed times (Fig. 8d–g).
MSC magnetic targeting
In order to verify if γ-Fe2O3-DMSA labeled MSC (80 µg/
mL, 24  h) became magnetically responsive, a test was 
previously performed in  vitro (Fig.  9a–d). Labeled cells 
were maintained in culture in the presence of an exter-
nal circular magnet or of a similar size plastic (control). It 
can be seen that the cells migrated toward the edge of the 
circular magnet (Fig. 9b, d), unlike the control group cells 
(Fig. 9a, c).
Next, we test the potential of in vivo magnetic target-
ing of γ-Fe2O3-DMSA labeled MSCs in an experimen-
tal mice model of lung silicosis. Histological analysis of 
experimental silicosis mice inoculated with γ-Fe2O3-
DMSA labeled MSC and with magnets fixed in their tho-
racic region presented higher iron content in their lung 
tissue than animals that did not hold external magnets 
(Fig.  9e). The light microscopy images also corroborate 
this data (Fig.  9f–h): animals treated with marked cells 
and holding magnets had more blue spots, correspond-
ing to γ-Fe2O3-DMSA, compared to animals without 
magnets.
Fig. 3 Analysis of MSC morphology by Instant Prov staining kit. a Negative control group. b Positive control group, with pyknotic nuclei (blue 
arrows) and normal nuclei (black arrows). c MSC incubated with Au-DMSA (90 μg/mL) and d with γ-Fe2O3-DMSA (80 μg/mL) for 24 h. Bars 50 
micrometers (μm)
Page 8 of 15Silva et al. J Nanobiotechnol  (2016) 14:59 
Fig. 4 Transmission electron microscopy micrographs of labeled MSC. a Unlabeled MSC (control). b γ-Fe2O3-DMSA labeled MSC (80 µg/mL); the 
white arrows point some of the uptaken nanoparticles. c MSC labeled with Au-DMSA (90 µg/mL); the white arrowheads point some of the uptaken 
nanoparticles. d Cells exposed to Au-DMSA for 24 h presented myelin figures (black arrows) and e more electron-lucent structures (white arrows) 
compared to unlabeled cells. f In turn, after 24 h of exposure toγ-Fe2O3-DMSA, MSC presented signs of mitochondrial toxicity: mitochondria full 
of nanoparticles are swollen and degenerated (black arrows), as compared to organelles without them (white arrows). g These cells also presented 
some myelin figures (black arrows). h Lastly, γ-Fe2O3-DMSA nanoparticles were stored in vesicles (white arrows). Nu nucleus, M mitochondria, RER 
rough endoplasmic reticulum, L lipid
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Discussion
This work had two main purposes: (1) to evaluate bio-
compatibility between MSC and DMSA-coated inorganic 
nanoparticles, verifying cytotoxic effects or physiological 
alterations; and (2) to test Au-DMSA and γ-Fe2O3-DMSA 
as agents for MSC in vivo tracking and for MSC magnetic 
targeting, respectively. Firstly, our results demonstrated 
the absence of toxic effects on MSC and suggested no sig-
nificant changes in physiological parameters such as cell 
differentiation, proliferation and immunomodulation, at 
the concentrations tested. In addition, Au-DMSA nano-
particles had a poor performance as MSC tracers when 
analyzed on a microtomograph; while γ-Fe2O3-DMSA 
showed to be good agent for magnetic targeting.
The results of MTT and trypan blue analysis dem-
onstrated the low toxicity of γ-Fe2O3-DMSA on MSC, 
corroborating with other studies [34, 35, 47, 48]. 
Although iron oxide catalyze free radicals production, 
chemical surface modifications make them safer materi-
als for biological applications [34, 49, 50]. For example, 
Auffan et  al. [34] suggested that is difficult to remove 
DMSA coating from the nanostructure (different than 
dextran or albumin), preventing direct contact of the cells 
with iron, protecting them from possible toxic effects. 
Thus, if the nanoparticle coating is easily degraded, the 
core can then react with cellular biomolecules [49].
Moreover, Chen et  al. [47] demonstrated that IONPs 
oxidative activity depends on the acidity of intracel-
lular microenvironment in which they are located. In 
lysosomes (low pH), IONPs produce more hydroxyl radi-
cals (OH−), increasing cell damage induced by H2O2. In 
neutral environments, IONPs break H2O2 into H2O and 
Fig. 5 MSC osteogenic differentiation assay. a–c Cytochemical analysis of differentiated MSC monolayers in light microscopy, with Alizarin Red, in 
order to evidence the formation of mineralized nodules. These nodules were present in control cells (a), in γ-Fe2O3-DMSA labeled cells, (b) and in 
Au-DMSA labeled cells (c). d Quantification of alizarin red incorporated in monolayers of differentiated and non-differentiated MSC; (*) Significant 
reduction in the group “MSC + Au-DMSA” compared to the groups “Unmarked MSC” and “MSC + γ-Fe2O3-DMSA” (p < 0.05). e Measurement of 
alkaline phosphatase (ALP) activity: data are represented as the average ratio of ALP activity and total protein content, with the respective standard 
deviations. There was no significant difference between control and experimental groups (p > 0.05). Bars 100 µm
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O2 [47]. In our work, TEM images showed few γ-Fe2O3-
DMSA in structures similar to lysosomes; most was 
located in MSC mitochondria, which are neutral pH 
organelles. Considering that, γ-Fe2O3-DMSA could not 
exert toxic effects to receptor MSC.
Otherwise, MTT tests showed significant differences 
between unlabeled MSC and Au-DMSA labeled MSC, 
suggesting harmful effects in their mitochondria. In spite 
of this, our data followed the same pattern found by Fan 
et  al. in 2009, which studied biocompatibility between 
gold nanoparticles (Au-NP) and MSC, using slightly 
lower gold concentrations (71,1  µg/mL) [51]. This simi-
larity suggests that MSC have a natural sensitivity to 
Au-NP, that is, the toxic effects observed are not related 
to Au-DMSA features, but to MSC cellular mechanisms 
that make them more or less vulnerable to label [50]. In 
addition, Fig.  1c shows that MSC viability increases 48 
and 72  h after exposure to Au-DMSA, which illustrates 
cellular recovery described by Mironava et  al. [24, 26]: 
damage caused by Au-NP marking are not permanent 
because, after nanoparticle exposure, gold cytoplas-
mic levels diminish and cells can completely recover 
their structures and/or altered functions. Interestingly, 
despite deleterious effects on mitochondrial metabolism 
(Fig.  2b), trypan blue tests (Fig.  2d) and cell morphol-
ogy analysis (Fig.  3) suggested that the Au-DMSA did 
not cause MSC death 24 h after exposure. So, we had to 
verify if these mitochondrial damages led to changes in 
important physiological parameters of cells; what was 
accomplished in the following experiments.
Some reports suggest that nanoparticles actively inter-
act with plasma membrane receptors, modulating sig-
nal transduction pathways, and inducing proliferation, 
immunomodulation, apoptosis or differentiation [52]. 
These harmful effects caused by altered cellular commu-
nication pathways cannot be detected only with viability 
tests, such as MTT and Trypan Blue. Therefore, MSC 
differentiation, MSC proliferation and lymphocyte sup-
pression tests were also performed. It is important to 
note that our study was the first that investigated nano-
particles effects on MSC immunomodulatory capacity. 
At the concentrations tested, both γ-Fe2O3-DMSA and 
Au-DMSA did not change this intrinsic property of cells, 
essential for the success of cellular therapies.
Fig. 6 MSC adipogenic differentiation assay. a–c Oil Red O cytochemical analysis of differentiated MSC monolayers in light microscopy, with in 
order to evidence the formation of intracellular lipid vesicles. These vesicles were seen in control cells (a), in γ-Fe2O3-DMSA labeled cells, (b) and in 
Au-DMSA labeled cells (c). d Quantification of Oil Red O incorporated in monolayers of differentiated and non-differentiated MSC, with no signifi-
cant difference between control and experimental groups (p > 0.05). Bars 50 µm
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In differentiation tests, MSC incubated with γ-Fe2O3-
DMSA showed no changes in adipogenesis and osteo-
genesis capacity, confirming previously published work 
[27]. Unlikely, Au-DMSA reduced MSC osteogenesis, 
corroborating Fan et al. data [51]. Although many studies 
in the literature describe Au-NP stimulus on osteogenic 
differentiation and mineralization [29, 53, 54], Fan et al. 
verified a reduction in ALP activity and in calcium depo-
sition, similar to our findings (Fig. 4). This disagreement 
may be caused by the Au-NP concentration used to label 
MSC: while 1.97 × 10−4 µg/mL induced differentiation in 
Zhang et al. report [54], 71.1 µg/mL inhibited osteogen-
esis in Fan et  al. study [51]. The higher Au-NP amount 
caused cytotoxic effects by oxidative stress, which 
represses both osteogenic and adipogenic differentiation 
[51].
In proliferation assays, labeled MSC proliferation rates 
presented no differences compared to respective con-
trol groups, except a significant increase in Au-DMSA 
labeled MSC amount, on the 2nd day. This result disa-
grees with data presented by Mironava et  al. [26]: MSC 
were incubated for 72 h with Au-NP (45 nm; 13, 20 and 
26  µg/mL) and proliferation rates were lower than con-
trols in all samples. The most notable difference between 
our study and Mironava et  al. study was the incubation 
times—MSC were exposed to Au-NP during 24 and 
72  h, respectively. Importantly, Mironava et  al. aimed 
to observe long-term effects (3–6  days) and cellular 
Fig. 7 a, b MSC proliferation curves. a Cells were incubated for 24 h with DMEM-LG (filled circle), or with DMEM-LG with diluted γ-Fe2O3-DMSA 
(filled square) (80 μg/mL), then were plated and counted after different times. There was no significant difference between the experimental groups 
(p > 0.05) in any count times. b Cells were incubated for 24 h with DMEM-LG (filled circle), or with DMEM-LG with diluted Au-DMSA (filled square) 
(90 μg/mL), then were plated and counted after different times. (*) Significant increase in Au-DMSA labeled MSC amount compared to the control 
group only on the second day (p < 0.05). c Analysis by flow cytometry of CFSE-marked lymphocytes, co-cultured with labeled and unlabeled 
MSC. The spectra shown are representative of assays performed in triplicate. Gray Line Lymphocytes not marked with CFSE; Black line not activated 
marked lymphocytes; Red Line activated marked lymphocytes; Blue line activated lymphocytes co-cultured with MSC; Yellow line activated lympho-
cytes co-cultured with γ-Fe2O3-DMSA labeled MSC; Green line activated lymphocytes co-cultured with Au-DMSA labeled MSC
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Fig. 8 Au-DMSA potential as a tracer for MSC tracking in computed microtomography. a–c Analysis of MSC precipitates in Sky-Scan 1640 microto-
mograph in which cross-sections of samples in Eppendorf tubes are represented: a water, b unlabeled MSC, c MSC labeled with Au-DMSA.  
d–g Sky-Scan 1640 images of longitudinal sections of mice. The animals were immediately analyzed after intranasal instillation with unlabeled cells 
(d) or with Au-DMSA labeled cells (e). Five days later, animals instilled with unlabeled cells (f) and Au-DMSA labeled cells (g) were analyzed again. 
Aw airways; H heart; L liver
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recovery on different cell lines exposed to Au-NP, high-
lighting the cytotoxic effects over long incubation times. 
On the other hand, to date, there are no reports of stimu-
lation of MSC proliferation by Au-NP. Together, all these 
data indicate that Au-DMSA nanoparticles are innocu-
ous labels for MSC.
Some reports have described that Au-NPs enable cell 
tracking in vivo by using computed tomography [5, 17]; 
however in our study we could not detect the signals 
generated by the Au-DMSA in a microtomograph. Some 
facts may explain this disagreement: (1) It is possible Au-
DMSA provided contrast to MSC, but not enough to dis-
tinguish them from the connective tissue associated with 
bronchi or the fibrous own tissue; (2) In our study, we 
injected an amount of labeled MSC lower than that used 
in other studies, for example, Menk et al. [17] inoculated 
107 cells , while we used between 0.5 and 1 × 106 cells, 
an amount we considered safe to prevent lung occlu-
sions; (3) The different tomography equipments used in 
our study and Menk et al. [17] study may also be a cause 
for the discrepancy observed. Menk et al. used an equip-
ment connected to a source of synchrotron radiation, 
resulting in images with higher contrast and better vis-
ibility of details such as cells labeled with Au-NPs [55]. 
In addition, Au-NPs-labeled MSC are usually inoculated 
systemically in tracking studies [5, 17]. However, in this 
work, we decided to check the feasibility of inoculating 
MSC via intranasal route which is a more direct route 
for respiratory disease treatments. On the other hand, 
our in  vitro and in  vivo assays demonstrated γ-Fe2O3-
DMSA potential for magnetic targeting of MSC. Quali-
tative (histological sections analysis) and quantitative 
Fig. 9 γ-Fe2O3-DMSA as a potential agent for MSC magnetic targeting. a–d Magnetic responsiveness test in vitro. a, b γ-Fe2O3-DMSA labeled cells 
were seeded in culture plates with a fixed plastic piece (a) or a circular magnet (b). The region in orange corresponds to the site where the materials 
were fixed. c, d The culture plates were examined by light microscopy in order to demonstrate the difference in amount of cells present in regions 
highlighted in red. e Iron measurement by colorimetric dosage of Prussian blue. Data refer to the mean ± SD from the mass of iron present in lungs, 
divided by lung’s weight. f–h Histological analysis of MSC retention in silicotic mice lungs. The slides were stained with Prussian Blue technique and 
contrasted with neutral red, evidencing iron from the γ-Fe2O3-DMSA in blue. f Healthy animal treated with saline g Animals treated with γ-Fe2O3-
DMSA labeled MSC without external magnets h Animal treated with labeled MSC and with external magnets
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assays (Prussian blue colorimetric dosage) showed a 
higher amount of iron in mice lungs which had magnets 
fixed in their bodies, suggesting a greater MSC retention. 
This was the first study that explored magnetic targeting 
of cells to the lung and our results raise the possibility 
of using this technique to enhance the effects of cellular 
therapy in lung diseases such as silicosis. Although it is 
known that pulmonary capillaries retains much of the 
systemically infused cells, there is evidence that this 
retention is not permanent [56], which may explain why 
beneficial effects of these cells in models of lung diseases 
do not last.
The findings of this study showed that iron and gold 
nanoparticles functionalized with DMSA, in the tested 
concentrations, were effectively uptaked by MSC, did not 
exert toxic effects, and did not induced changes in MSCs 
function (differentiation capacity, proliferation and inhi-
bition of T lymphocytes). In addition, our results suggest 
the use of γ-Fe2O3-DMSA as agents for magnetic target-
ing of MSCs.
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